Related News:-
Gilead Sciences Announces First Quarter 2011 Financial Results
Gilead Sciences, Inc. (Nasdaq:GILD) announced today its results of operations for the quarter ended March 31, 2011. Total revenues for the first quart
Gilead Sciences Announces Third Quarter 2010 Financial Results
Gilead Sciences, Inc. (Nasdaq:GILD) announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third q
Gilead Sciences Announces First Quarter 2011 Financial Results ...
- Product Sales of $1.86 Billion, Up 4 Percent over First Quarter 2010 - - Antiviral Product Sales of $1.63 Billion, Up 2 Percent over First Quarter 2010 -
Gilead Sciences Announces First Quarter 2011 Financial Results
Gilead Sciences Announces First Quarter 2011 Financial Results - Product Sales of $1.86 Billion, Up 4 Percent over First Quarter 2010 - - Antiviral Product Sales of ...
Gilead Sciences to Release Second Quarter 2011 Financial Results ...
{Businesswire via BioPortfolio} Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its second quarter 2011 financial results will be released on Tuesday,...
Gilead Sciences Announces First Quarter 2011 Financial Results ...
More on Press Releases. Cornerstone Community Bank Reports Financial Results For The Second Quarter Ended June 30, 2011 And The Opening Of A New Branch In Redding
Gilead Sciences to Release Second Quarter 2011 Financial Results ...
press release. July 19, 2011, 4:30 p.m. EDT Gilead Sciences to Release Second Quarter 2011 Financial Results on Tuesday, July 26, 2011 Conference Call and Webcast to ...
Human Genome Sciences Announces Second Quarter 2011 Financial ...
BENLYSTA® U.S. launch progressing well European Commission approval of BENLYSTA received July 13, 2011 Health Canada approval of BENLYSTA received July 6, 2011 ROCKVILLE ...
GEN | Industry Updates: Gilead Sciences to Release Second Quarter ...
Industry Updates: Jul 19, 2011 Gilead Sciences to Release Second Quarter 2011 Financial Results on Tuesday, July 26, 2011
No comments:
Post a Comment